Zydus Lifesciences Statistics
Total Valuation
Zydus Lifesciences has a market cap or net worth of INR 1.11 trillion. The enterprise value is 1.12 trillion.
Market Cap | 1.11T |
Enterprise Value | 1.12T |
Important Dates
The next estimated earnings date is Thursday, November 14, 2024.
Earnings Date | Nov 14, 2024 |
Ex-Dividend Date | Jul 26, 2024 |
Share Statistics
Zydus Lifesciences has 1.01 billion shares outstanding. The number of shares has decreased by -0.20% in one year.
Shares Outstanding | 1.01B |
Shares Change (YoY) | -0.20% |
Shares Change (QoQ) | -0.50% |
Owned by Insiders (%) | 75.08% |
Owned by Institutions (%) | 14.43% |
Float | 249.06M |
Valuation Ratios
The trailing PE ratio is 26.67 and the forward PE ratio is 24.02. Zydus Lifesciences's PEG ratio is 1.46.
PE Ratio | 26.67 |
Forward PE | 24.02 |
PS Ratio | 5.39 |
PB Ratio | 5.58 |
P/FCF Ratio | n/a |
PEG Ratio | 1.46 |
Enterprise Valuation
EV / Earnings | 26.82 |
EV / Sales | 5.45 |
EV / EBITDA | 18.93 |
EV / EBIT | 21.64 |
EV / FCF | n/a |
Financial Position
Current Ratio | n/a |
Quick Ratio | n/a |
Debt / Equity | 3.72 |
Debt / EBITDA | 0.14 |
Debt / FCF | n/a |
Interest Coverage | 87.44 |
Financial Efficiency
Return on Equity (ROE) | n/a |
Return on Assets (ROA) | n/a |
Return on Capital (ROIC) | 14.50% |
Revenue Per Employee | 7.66M |
Profits Per Employee | 1.56M |
Employee Count | 26,921 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +72.85% in the last 52 weeks. The beta is 0.46, so Zydus Lifesciences's price volatility has been lower than the market average.
Beta (5Y) | 0.46 |
52-Week Price Change | +72.85% |
50-Day Moving Average | 1,171.06 |
200-Day Moving Average | 950.77 |
Relative Strength Index (RSI) | 37.39 |
Average Volume (20 Days) | 4,446,188 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Zydus Lifesciences had revenue of INR 206.15 billion and earned 41.93 billion in profits. Earnings per share was 41.49.
Revenue | 206.15B |
Gross Profit | 143.10B |
Operating Income | 50.81B |
Pretax Income | 54.95B |
Net Income | 41.93B |
EBITDA | 58.08B |
EBIT | 50.81B |
Earnings Per Share (EPS) | 41.49 |
Balance Sheet
The company has 13.58 billion in cash and 8.22 billion in debt, giving a net cash position of 5.36 billion or 5.32 per share.
Cash & Cash Equivalents | 13.58B |
Total Debt | 8.22B |
Net Cash | 5.36B |
Net Cash Per Share | 5.32 |
Equity (Book Value) | 221.02B |
Book Value Per Share | 197.07 |
Working Capital | n/a |
Cash Flow
Operating Cash Flow | n/a |
Capital Expenditures | n/a |
Free Cash Flow | n/a |
FCF Per Share | n/a |
Margins
Gross margin is 69.41%, with operating and profit margins of 24.64% and 20.34%.
Gross Margin | 69.41% |
Operating Margin | 24.64% |
Pretax Margin | 26.66% |
Profit Margin | 20.34% |
EBITDA Margin | 28.17% |
EBIT Margin | 24.64% |
FCF Margin | n/a |
Dividends & Yields
This stock pays an annual dividend of 3.00, which amounts to a dividend yield of 0.27%.
Dividend Per Share | 3.00 |
Dividend Yield | 0.27% |
Dividend Growth (YoY) | -50.00% |
Years of Dividend Growth | 1 |
Payout Ratio | n/a |
Buyback Yield | 0.20% |
Shareholder Yield | 0.48% |
Earnings Yield | 3.77% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 6, 2015. It was a forward split with a ratio of 5.
Last Split Date | Oct 6, 2015 |
Split Type | Forward |
Split Ratio | 5 |